RxSight Inc (RXST)
45.64
+0.59
(+1.31%)
USD |
NASDAQ |
Nov 22, 13:25
RxSight Revenue (TTM): 128.29M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 128.29M |
| June 30, 2024 | 115.18M |
| March 31, 2024 | 101.10M |
| December 31, 2023 | 89.08M |
| September 30, 2023 | 76.59M |
| June 30, 2023 | 67.00M |
| March 31, 2023 | 57.55M |
| December 31, 2022 | 49.00M |
| Date | Value |
|---|---|
| September 30, 2022 | 41.34M |
| June 30, 2022 | 34.51M |
| March 31, 2022 | 28.05M |
| December 31, 2021 | 22.59M |
| September 30, 2021 | 19.08M |
| June 30, 2021 | 17.46M |
| March 31, 2021 | 15.27M |
| December 31, 2020 | 14.68M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
14.68M
Minimum
Dec 2020
128.29M
Maximum
Sep 2024
54.80M
Average
45.17M
Median
Revenue (TTM) Benchmarks
| Tandem Diabetes Care Inc | 854.35M |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 38.27M |
| Xtant Medical Holdings Inc | 113.86M |
| Catheter Precision Inc | 0.399M |